論文 - 詳細
| RRC ID | 78679 |
|---|---|
| 著者 | Nakayama H, Saito N, Kasajima R, Suganuma N, Rino Y, Masudo K, Yamazaki H, Toda S, Sekihara K, Iwasaki H, Hoshino D. |
| タイトル | Validation of EZH2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell Lines. |
| ジャーナル | Anticancer Res |
| Abstract |
BACKGROUND/AIM:The prognosis of anaplastic thyroid carcinoma (ATC) is poor, and there is currently no established treatment to improve its outcome. We previously reported that enhancer of zeste homolog 2 (EZH2) was highly expressed in ATC, and may be a therapeutic target; however, the effects of EZH2 on ATC growth currently remain unknown. MATERIALS AND METHODS:We investigated the effects of an EZH2 inhibitor (DZNep) on four ATC cell lines (8305C, KTA1, TTA1 and TTA2). We performed a gene panel analysis of all ATC cell lines to identify differences in DZNep sensitivity between the cell lines. To investigate the effects of DZNep on the recovery of differentiation, we assessed changes in thyroid differentiation markers (TDMs) before and after the DZNep treatment using PCR. RESULTS:EZH2 was expressed in all ATC cell lines. The cell-reducing effects of DZNep were detected in all ATC cell lines, and were the strongest in KTA1 cells followed by TTA2 cells. The TTA1 and 8305C cell lines, which showed weak cell-reducing effects, had TP53 mutations. No changes in TDMs were observed in any ATC cell line. CONCLUSION:DZNep, an EZH2 inhibitor, exerted suppressive effects on the growth of ATC cell lines and has potential as a therapeutic strategy; however, its effects may be attenuated in ATC with TP53 mutations. |
| 巻・号 | 43(3) |
| ページ | 1073-1077 |
| 公開日 | 2023-3-1 |
| DOI | 10.21873/anticanres.16252 |
| PII | 43/3/1073 |
| PMID | 36854530 |
| MeSH | Cell Differentiation Cell Line Enhancer of Zeste Homolog 2 Protein* / antagonists & inhibitors Humans Thyroid Carcinoma, Anaplastic* / drug therapy Thyroid Carcinoma, Anaplastic* / genetics Thyroid Neoplasms* / drug therapy Thyroid Neoplasms* / genetics |
| リソース情報 | |
| ヒト・動物細胞 | 8305C(RCB1909) |